IRIS UniCatt

Baranello, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.769
NA - Nord America 1.560
AS - Asia 806
SA - Sud America 181
AF - Africa 19
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.340
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.524
DE - Germania 704
CN - Cina 297
SG - Singapore 292
SE - Svezia 246
IT - Italia 164
BR - Brasile 163
FR - Francia 142
IE - Irlanda 95
UA - Ucraina 95
GB - Regno Unito 94
ID - Indonesia 58
FI - Finlandia 55
RU - Federazione Russa 49
IN - India 42
KR - Corea 34
BE - Belgio 21
TR - Turchia 19
HK - Hong Kong 18
PL - Polonia 16
CA - Canada 15
NL - Olanda 15
AT - Austria 14
MK - Macedonia 12
RS - Serbia 12
CH - Svizzera 9
MX - Messico 8
CZ - Repubblica Ceca 7
EG - Egitto 7
AR - Argentina 6
PA - Panama 6
CI - Costa d'Avorio 5
IL - Israele 5
IR - Iran 5
LT - Lituania 5
PE - Perù 4
UZ - Uzbekistan 4
VN - Vietnam 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
IQ - Iraq 3
TH - Thailandia 3
AM - Armenia 2
BD - Bangladesh 2
BY - Bielorussia 2
CO - Colombia 2
CR - Costa Rica 2
GE - Georgia 2
GR - Grecia 2
JP - Giappone 2
LU - Lussemburgo 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
TN - Tunisia 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AU - Australia 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ES - Italia 1
GT - Guatemala 1
JM - Giamaica 1
KE - Kenya 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PK - Pakistan 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 4.340
Salva come PNG Salva come JPEG
Città #
Chandler 311
Singapore 202
Ashburn 115
New York 104
Dublin 78
Jacksonville 67
Jakarta 58
Ann Arbor 55
San Mateo 47
Munich 40
Nürnberg 40
Dearborn 38
Milan 37
Hefei 36
Los Angeles 36
Marseille 36
Seattle 35
Wilmington 34
Nanjing 33
Seoul 33
Rome 29
Boston 28
Moscow 28
Frankfurt am Main 26
Woodbridge 21
Princeton 20
Brussels 18
Helsinki 18
Houston 18
Beijing 17
Fairfield 17
Hong Kong 17
Lancaster 17
São Paulo 17
Bremen 16
Nanchang 16
Nuremberg 15
Turku 13
Augusta 12
Düsseldorf 12
Lawrence 12
Palermo 12
Paris 12
London 11
Leawood 10
Pune 10
Redwood City 10
Skopje 10
Changsha 9
Hangzhou 9
Norwalk 9
Chicago 8
Hebei 8
Jinan 7
Portsmouth 7
Amsterdam 6
Boardman 6
Brasília 6
Cambridge 6
Fremont 6
Jiaxing 6
Lauterbourg 6
Menlo Park 6
Ningbo 6
Niš 6
Ribeirão Preto 6
Vienna 6
Washington 6
Wroclaw 6
Zhengzhou 6
Abidjan 5
Bexley 5
Brno 5
Cattolica 5
Columbus 5
Guangzhou 5
Izmir 5
San Francisco 5
Shenyang 5
Tianjin 5
Warsaw 5
Atlanta 4
Belgrade 4
Bern 4
Buffalo 4
Cairo 4
Harrisburg 4
Hyderabad 4
Kish 4
Lappeenranta 4
Lima 4
Montreal 4
Rio de Janeiro 4
Roubaix 4
Salvador 4
Santa Clara 4
Secaucus 4
The Dalles 4
Toronto 4
Ankara 3
Totale 2.174
Salva come PNG Salva come JPEG
Nome #
Cortical visual function in preterm infants in the first year. 225
Neurological examination at 6 to 9 months in infants with cystic periventricular leukomalacia 180
Prognostic value of EEG performed at term age in preterm infants. 170
-Thalamic atrophy in infants with PVL and cerebral visual impairment 153
Visual development in prenatal post-haemorragic ventricular dilatation 136
External hydrocephalus in discordant birth weight twins: a case report 135
Sleep disturbances in preschool age children with cerebral palsy: a questionnaire study 132
Antenatal post-hemorragic ventriculomegaly: a prospective follow-up study 131
Early development in Dravet syndrome; visual function impairment precedes cognitive decline 126
Sleep disturbances in preschool age children with cerebral palsy: a questionnaire study 117
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivity 114
Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standars of Care? 111
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 111
antenatal post hemorrhagic ventriculomegaly: a prospective follow up study 97
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivity 97
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 93
Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol 88
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial 88
Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data. 87
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 87
Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study 83
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 82
6 minute walk test in duchenne MD patients with different mutations:12 month changes 80
Revised north star ambulatory assessment for young boys with Duchenne muscular dystrophy 80
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 80
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 79
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 76
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatment 71
Registries versus tertiary care centers: How do we measure standards of care in Duchenne muscular dystrophy? 71
Implicit learning deficit in children with Duchenne muscular dystrophy: Evidence for a cerebellar cognitive impairment? 70
Longitudinal natural history in young boys with Duchenne muscular dystrophy 69
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 64
The nonsense mutation stop+4 model correlates with motor changes in Duchenne muscular dystrophy 64
Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy 62
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 55
Risdiplam in Type 1 Spinal Muscular Atrophy 54
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 52
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants 51
Development of an International SMA Bulbar Assessment for Inter-professional Administration 50
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 47
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial 45
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study 43
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial 41
The emerging spectrum of neurodevelopmental comorbidities in early-onset Spinal Muscular Atrophy 39
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 38
Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements 34
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 33
Erratum: Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-month changes (PLoS ONE (2015) 10:12 (e0144079)) 33
Type I spinal muscular atrophy and disease modifying treatments: a nationwide study in children born since 2016 32
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 30
Genetic modifiers of upper limb function in Duchenne muscular dystrophy 28
Genetic modifiers of respiratory function in Duchenne muscular dystrophy 28
Longitudinal data of neuropsychological profile in a cohort of Duchenne muscular dystrophy boys without cognitive impairment 27
The neurological examination of the newborn baby 20
Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 (PLoS ONE (2019) 14:6 (e0218683) DOI: 10.1371/journal.pone.0218683) 20
Severe abnormalities of the pons in two infants with Goldenhar syndrome 19
Visual findings in infants with periventricular leukomalacia: 139 19
Visual development in infants with prenatal posthaemorrhagic ventricular dilatation 18
Cognitive profile in Duchenne muscular dystrophy boys without intellectual disability: The role of executive functions 18
Correction to: Two‑year efficacy and safety of risdiplam in patients with type 2 or non‑ambulant type 3 spinal muscular atrophy (SMA) 15
Totale 4.398
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.679
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.679
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 0 0 0 0 0 0 0 0 0 0 0 20
2020/2021211 19 25 3 18 18 13 31 5 29 16 31 3
2021/2022384 19 17 19 41 25 15 7 64 29 23 61 64
2022/2023931 104 124 59 144 54 112 45 79 136 10 40 24
2023/2024610 31 126 18 39 21 132 59 18 5 23 63 75
2024/20251.224 24 25 97 43 121 72 53 55 161 108 317 148
Totale 4.398